Nuuron

Developer of a digital drug to treat Alzheimer's disease

placeBerlin, Berlin, Germany calendar_todayFounded 2023 language nuuron.com

Social engagement

Social engagement: 1.2K social following, 4 posts in the last 12 months — below the industry typical range.

Investor mix

4 investors on record; lead investors include HTGF.

Investor typeCountShare
Venture capital375%
Angel & family office125%

Recent activity

2 Jul 2026
Event
SAMBA conference (Salzburg Mind Brain Annual Meeting)
17 Mar 2026
Event
AD/PD - Advances in Science & Therapy
24 Nov 2025
Event
CTAD Clinical Trials on Alzheimer's Disease
Coming soon